FDA Drug Info has posted new Drug Safety Podcasts for Healthcare Professionals. Click on the following links to read transcripts and listen to podcasts.
Sprycel (dasatinib) and risk of pulmonary arterial hypertension:
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm275517.htm
Updated information about the drug interaction between methylene blue and serotonergic psychiatric medications:
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm276919.htm
Updated information about the drug interaction between linezolid (Zyvox) and serotonergic psychiatric medications:
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm276917.htm
Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events:
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm277065.htm
Voluntary market withdrawal of Xigris [drotrecogin alfa (activated)] due to failure to show a survival benefit:http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm277212.htm
Updated information about the FDA-funded study on risk of blood clots in women taking birth control pills containing drospirenone:
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm277596.htm
You can download other Drug Safety Podcasts at: FDA Drug Safety Podcasts by Date or subscribe to the Drug Safety Podcasts channel in iTunes at: Drug Safety Podcasts:
open here please:
Drug Safety Podcasts > FDA Drug Safety Podcasts by Date
martes, 1 de noviembre de 2011
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario